Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
Jun Iwamoto1, Yoshihiro Sato2, Tsuyoshi Takeda1, Hideo Matsumoto21Department of Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, JapanAbstract: Osteoporosis most commonly affects postmenopausal women, placing them at a significant...
Main Authors: | Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda, Hideo Matsumoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-09-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/hip-fracture-protection-by-alendronate-treatment-in-postmenopausal-wom-peer-reviewed-article-CIA |
Similar Items
-
Study of DXA-derived lateral–medial cortical bone thickness in assessing hip fracture risk
by: Yujia Long, et al.
Published: (2015-06-01) -
Study of DXA-derived cortical bone thickness in assessing hip fracture risk
by: Long, Yujia
Published: (2014) -
Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
by: Tsuchiya K, et al.
Published: (2019-08-01) -
The Effect of Hypercholesterolemia on Cortical Bone Thickness of Wistar Rats (Rattus norvegicus)
by: Auliya Dzaqiyatus Sofka, et al.
Published: (2021-01-01) -
Growth and Age-Related Abnormalities in Cortical Structure and Fracture Risk
by: Ego Seeman
Published: (2015-12-01)